Loading…
Sectoral / Thematic · Nippon India Mutual Fund · AMFI code 102431Nippon India Pharma Fund
Disclosed for 84 months, Sep 2019 to Aug 2026.Published as: NIPPON INDIA PHARMA FUND (An Open Ended Equity Scheme Investing In Pharma Sector)
Portfolio value
₹8,648 Cr
up ₹508 Cr vs Jul 2024
- Stocks held
- 33
- up 1 vs Jul 2024
- Top 10 weight
- 60.0%
- of the portfolio in its ten largest
- Cash & debt
- 2.6%
- cash, money market and debt
- Moves this month
- 1 in · 0 out
- added to 10, trimmed 4
Nippon India Pharma Fund is an active equity fund in the Sectoral / Thematic category from Nippon India Mutual Fund. In August 2024 it disclosed 33 stocks worth ₹8,648 Cr, up ₹508 Cr from Jul 2024. Its largest positions were Sun Pharmaceutical Industries Limited (13.8%), Lupin Limited (8.3%), Divi's Laboratories Limited (8.0%); the ten largest together made up 60.0% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 79.0% of its equity. Cash and debt stood at 2.6%. Compared with Jul 2024 the fund entered 1 new stock and exited 0.
Against 226 other Sectoral / Thematic funds
Concentration
84%
Top-10 weight is higher than 84% of peers
Breadth
18%
Holds more stocks than 18% of peers
Cash
38%
Holds more cash than 38% of peers
Holdings in August 2024
Download CSVEvery line the fund disclosed, with the change against Jul 2024. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 13.81%
- Δ weight
- down 0.04 pts
- Value
- ₹1,194 Cr
- Δ value
- up ₹67.1 Cr
- Status
- Added
- Weight
- 8.30%
- Δ weight
- up 0.77 pts
- Value
- ₹718 Cr
- Δ value
- up ₹105 Cr
- Status
- Added
- Weight
- 7.96%
- Δ weight
- down 0.21 pts
- Value
- ₹688 Cr
- Δ value
- up ₹23.1 Cr
- Status
- Added
- Weight
- 5.93%
- Δ weight
- up 0.05 pts
- Value
- ₹513 Cr
- Δ value
- up ₹34.3 Cr
- Status
- Added
- Weight
- 5.69%
- Δ weight
- down 0.11 pts
- Value
- ₹492 Cr
- Δ value
- up ₹19.7 Cr
- Status
- Added
- Weight
- 5.20%
- Δ weight
- down 0.08 pts
- Value
- ₹449 Cr
- Δ value
- up ₹20.3 Cr
- Status
- Added
- Weight
- 3.60%
- Δ weight
- up 0.42 pts
- Value
- ₹311 Cr
- Δ value
- up ₹52.6 Cr
- Status
- Added
- Weight
- 3.19%
- Δ weight
- up 0.25 pts
- Value
- ₹276 Cr
- Δ value
- up ₹36.9 Cr
- Status
- Added
- Weight
- 3.19%
- Δ weight
- down 0.76 pts
- Value
- ₹276 Cr
- Δ value
- down ₹45.5 Cr
- Status
- Trimmed
- Weight
- 3.09%
- Δ weight
- down 0.08 pts
- Value
- ₹267 Cr
- Δ value
- up ₹8.9 Cr
- Status
- Added
- Weight
- 3.02%
- Δ weight
- up <0.01 pts
- Value
- ₹261 Cr
- Δ value
- up ₹15.6 Cr
- Status
- Added
- Weight
- 2.94%
- Δ weight
- down 1.20 pts
- Value
- ₹254 Cr
- Δ value
- down ₹83 Cr
- Status
- Trimmed
- Weight
- 2.89%
- Δ weight
- down 0.13 pts
- Value
- ₹250 Cr
- Δ value
- up ₹3.7 Cr
- Status
- Added
- Weight
- 2.64%
- Δ weight
- down 0.15 pts
- Value
- ₹229 Cr
- Δ value
- up ₹1.2 Cr
- Status
- Added
- Cash, TREPS & receivables
- Weight
- 2.60%
- Δ weight
- up 1.06 pts
- Value
- ₹225 Cr
- Δ value
- up ₹99.3 Cr
- Status
- Added
- Weight
- 2.59%
- Δ weight
- up 0.35 pts
- Value
- ₹224 Cr
- Δ value
- up ₹41.4 Cr
- Status
- Added
- Weight
- 2.42%
- Δ weight
- down 0.15 pts
- Value
- ₹209 Cr
- Δ value
- down ₹15 L
- Status
- Held
- Weight
- 2.23%
- Δ weight
- up 0.02 pts
- Value
- ₹193 Cr
- Δ value
- up ₹13.2 Cr
- Status
- Added
- Weight
- 2.20%
- Δ weight
- down 0.11 pts
- Value
- ₹190 Cr
- Δ value
- up ₹1.9 Cr
- Status
- Added
- Weight
- 2.03%
- Δ weight
- up 0.07 pts
- Value
- ₹175 Cr
- Δ value
- up ₹15.8 Cr
- Status
- Added
- Weight
- 1.98%
- Δ weight
- up 0.17 pts
- Value
- ₹171 Cr
- Δ value
- up ₹23.9 Cr
- Status
- Added
- Weight
- 1.81%
- Δ weight
- down 0.06 pts
- Value
- ₹157 Cr
- Δ value
- up ₹4.6 Cr
- Status
- Added
- Weight
- 1.79%
- Δ weight
- up 0.06 pts
- Value
- ₹155 Cr
- Δ value
- up ₹14 Cr
- Status
- Added
- Weight
- 1.76%
- Δ weight
- down 0.01 pts
- Value
- ₹152 Cr
- Δ value
- up ₹7.8 Cr
- Status
- Added
- Weight
- 1.28%
- Δ weight
- down 0.33 pts
- Value
- ₹111 Cr
- Δ value
- down ₹20.3 Cr
- Status
- Trimmed
- Weight
- 1.13%
- Δ weight
- up 0.01 pts
- Value
- ₹97.7 Cr
- Δ value
- up ₹6.9 Cr
- Status
- Added
- Weight
- 1.10%
- Δ weight
- up 0.03 pts
- Value
- ₹94.8 Cr
- Δ value
- up ₹7.6 Cr
- Status
- Added
- Weight
- 0.93%
- Δ weight
- down 0.06 pts
- Value
- ₹80.6 Cr
- Δ value
- —
- Status
- Held
- Weight
- 0.77%
- Δ weight
- up 0.02 pts
- Value
- ₹66.3 Cr
- Δ value
- up ₹5.3 Cr
- Status
- Added
- Weight
- 0.49%
- Δ weight
- up 0.01 pts
- Value
- ₹42.3 Cr
- Δ value
- up ₹3.1 Cr
- Status
- Added
- Weight
- 0.49%
- Δ weight
- down 0.07 pts
- Value
- ₹42.2 Cr
- Δ value
- down ₹2.9 Cr
- Status
- Trimmed
- Weight
- 0.40%
- Δ weight
- up 0.01 pts
- Value
- ₹34.9 Cr
- Δ value
- up ₹3.1 Cr
- Status
- Added
- Weight
- 0.29%
- Δ weight
- down 0.01 pts
- Value
- ₹24.9 Cr
- Δ value
- up ₹38 L
- Status
- Added
- Weight
- 0.27%
- Δ weight
- up 0.27 pts
- Value
- ₹23.4 Cr
- Δ value
- up ₹23.4 Cr
- Status
- New
What changed, Jul 2024 to Aug 2024
New New positions (1)
- Krishna Institute Of Medical Sciences Limited0.3% · ₹23.4 Cr
Exited Exited (0)
None.
Added Biggest additions
- Lupin Limitedup ₹105 Cr (+0.77% pts)
- Sun Pharmaceutical Industries Limitedup ₹67.1 Cr (−0.04% pts)
- Ajanta Pharma Limitedup ₹52.6 Cr (+0.42% pts)
- Mankind Pharma Limitedup ₹41.4 Cr (+0.35% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Jul 2024, the weight rose most in Healthcare Services (+0.3 pts), and fell most in Pharmaceuticals & Biotechnology (−0.2 pts) and Retailing (−0.1 pts).
- Healthcare Services17.4% → 17.7%+0.3 pts
- Pharmaceuticals & Biotechnology79.2% → 79.0%−0.2 pts
- Retailing2.6% → 2.5%−0.1 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Aug 2021 | Aug 2023 | Feb 2024 | May 2024 | Jul 2024 | Aug 2024 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 73.6% | 77.8% | 78.9% | 78.2% | 79.2% | 79.0% |
| Healthcare Services | 23.7% | 16.3% | 17.2% | 17.9% | 17.4% | 17.7% |
| Retailing | — | 4.7% | 3.1% | 3.2% | 2.6% | 2.5% |
| Pharmaceuticals | 2.2% | 1.1% | 0.9% | 0.8% | 0.8% | 0.8% |
Allocation in Aug 2024change vs Jul 2024
- Pharmaceuticals & Biotechnology (22)79.0%▼ 0.2 pts
- Healthcare Services (9)17.7%▲ 0.3 pts
- Retailing (1)2.5%▼ 0.1 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Aug 2024
2.6%
▲ 1.1 pts vs Jul 2024
- Cash alone
- 2.6%
- cash and net receivables
- A year earlier
- 3.2%
- Aug 2023 · now ▼ 0.6 pts
- Last 12 months
- 0.5% – 3.9%
- lowest to highest · record 5.9% in May 2021
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.